ZA807816B - Cyclic peptide nuclei - Google Patents

Cyclic peptide nuclei

Info

Publication number
ZA807816B
ZA807816B ZA00807816A ZA807816A ZA807816B ZA 807816 B ZA807816 B ZA 807816B ZA 00807816 A ZA00807816 A ZA 00807816A ZA 807816 A ZA807816 A ZA 807816A ZA 807816 B ZA807816 B ZA 807816B
Authority
ZA
South Africa
Prior art keywords
cyclic peptide
peptide nuclei
nuclei
cyclic
peptide
Prior art date
Application number
ZA00807816A
Inventor
B Abbott
D Fukuda
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA807816B publication Critical patent/ZA807816B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA00807816A 1979-12-13 1980-12-12 Cyclic peptide nuclei ZA807816B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10301679A 1979-12-13 1979-12-13

Publications (1)

Publication Number Publication Date
ZA807816B true ZA807816B (en) 1982-07-28

Family

ID=22292913

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00807816A ZA807816B (en) 1979-12-13 1980-12-12 Cyclic peptide nuclei

Country Status (3)

Country Link
JP (1) JPS56120655A (en)
BE (1) BE886577A (en)
ZA (1) ZA807816B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567236A (en) * 1983-07-18 1986-01-28 The Upjohn Co. Novel polymer blends
DE102004060750A1 (en) * 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Process for the deacylation of lipopeptides

Also Published As

Publication number Publication date
JPH0238600B2 (en) 1990-08-31
BE886577A (en) 1981-06-10
JPS56120655A (en) 1981-09-22

Similar Documents

Publication Publication Date Title
DE3067731D1 (en) Cryostat
JPS5628770A (en) Injector
AU2912777A (en) Cyclic peptide derivatives
JPS5620465A (en) Injector
JPS5676957A (en) Injector
SG76083G (en) Peptides
PH15683A (en) Immunopotentiating peptides
AU513702B2 (en) Peptides
GB2065131B (en) Cyclic peptide nuclei
JPS5647654A (en) Tester
IL61648A0 (en) Derivatives of cyclic peptide nuclei
IL61649A0 (en) Derivatives of cyclic peptide nuclei
GB2049201B (en) Carrier-domain magnetometers
AU2727977A (en) Peptides
JPS5649161A (en) Injector
JPS5611066A (en) Injector
ZA807815B (en) Derivatives of cyclic peptide nuclei
ZA807816B (en) Cyclic peptide nuclei
GB1541337A (en) Peptides
JPS5594341A (en) N*nndisubstituted aminomethylphenylethanolamines
JPS56115754A (en) Cyclic peptide nucleus derivative
AU6533680A (en) Cyclic peptide nuclei
GB2055608B (en) Sample injection
IE802610L (en) Cyclic peptide nuclei
JPS5621069A (en) Multiitrace oscilloscope